SCHEMBL6734173

SCHEMBL6734173

CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2ccccc2C(F)(F)F)c1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6727832 0.87 GRM2 (0.66) GRM2
SCHEMBL6738307 0.85 GRM2 (0.67) GRM2
SCHEMBL6734090 0.85 GRM2 (0.66) GRM2
SCHEMBL6733027 0.85 GRM2 (0.66) GRM2
SCHEMBL6732204 0.84 GRM2 (0.78) GRM2
SCHEMBL6735434 0.83 GRM2 (0.64) GRM2
SCHEMBL6728289 0.81 GRM2 (0.61) GRM2
SCHEMBL6733481 0.80 GRM2 (0.65) GRM2
SCHEMBL6733084 0.79 GRM2 (0.80) GRM2
SCHEMBL6732879 0.77 GRM2 (0.82) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006114-A1 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-01-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006114-A1 Potentiators of glutamate receptors GRM1, GRIN1, GRM2 GRM2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.